HemaVision develops and industrializes a technological platform for the cellular quality control market, based on a patented cell‑labeling process and three‑dimensional morphological cell analysis. This modeling is converted into actionable, industry‑ready indicators to anticipate production anomalies in cell therapies, bioproduction, and cell culture processes, with mid‑term applications in blood products and broader biomedical fields.
With over 15 years of scientific experience in cellular and molecular biology, Andrei Constantinescu holds a PhD in Cellular and Molecular Biology from the University of Strasbourg, followed by a postdoctoral fellowship at the Laboratory of Excellence LipSTIC (INSERM, Dijon). His background also includes two years as a scientific editor at a European academic publishing house (TRIVENT), providing strong expertise in scientific communication and peer‑review processes. In addition, he has more than five years of experience as a Scientific Advisor in molecular oncology at Qiagen, a global biotechnology leader in molecular biology solutions, supporting translational research and precision medicine initiatives.